{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T13:14:31Z","timestamp":1784294071573,"version":"3.55.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>Radioactive iodine therapy (RAI) \u2265100\u00a0mCi (3.7\u00a0GBq) is commonly recommended for papillary thyroid cancer (PTC) patients with extranodal extension (ENE). However, no study has evaluated whether RAI \u2265100\u00a0mCi is effective in reducing the recurrence of PTC with ENE.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This retrospective cohort study enrolled 191 PTC patients with ENE who underwent total thyroidectomy and RAI. Recurrence according to RAI activity (&lt;100 vs. \u2265100\u00a0mCi) was compared before and after propensity score matching (PSM) (1:2) using Kaplan-Meier curves and Cox proportional hazards regression models. Subgroup analyses according to mass size (&lt;4 and \u22654\u00a0cm), gender, blood vessel invasion, lymph node (LN) number (\u22645 and &gt;5), and stimulated Tg (sTg) level (&lt;10 and \u226510\u00a0ng\/mL) before and after PSM were performed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>During about 116 months, 5 (12.5%) and 19 (12.6%) before PSM, five (12.5%) and 3 (3.8%) after PSM recorded recurrence in &lt;100 and \u2265100\u00a0mCi groups, respectively. The impact of RAI \u2265100\u00a0mCi on reducing recurrence was not significant before [log-rank <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.915, adjusted hazard ratio (HR) 0.49 (0.12\u20131.85); <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.294) and after PSM (log-rank <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.077). Subgroup analysis after PSM demonstrated the impact of RAI \u2265100\u00a0mCi on lowering recurrence only in ENE patients with mass size \u22654\u2003cm (log-rank <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.008), LN &gt;5 (log-rank <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.007), and sTg \u226510\u00a0ng\/mL (log-rank <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.039).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>In PTC patients with ENE, mass size \u22654\u00a0cm, LN &gt;5, or sTg \u226510\u00a0ng\/mL had a benefit from RAI \u2265100\u00a0mCi compared with RAI &lt;100\u00a0mCi.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rlu.0000000000005940","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T06:00:21Z","timestamp":1747116021000},"page":"830-839","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Impact of Therapeutic Radioactive Iodine on the Recurrence of Papillary Thyroid Cancer With Extranodal Extension in Metastatic Lymph Nodes: A Propensity Score-matched Analysis"],"prefix":"10.1097","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7865-0172","authenticated-orcid":false,"given":"Hye In","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Endocrinology and Metabolism, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7182-3877","authenticated-orcid":false,"given":"Boram","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology & Metabolism, Thyroid Center, Samsung Medical Center, Sungkyunkwan University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3074-4142","authenticated-orcid":false,"given":"Jiyeon","family":"Hyeon","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nak Gyeong","family":"Ko","sequence":"additional","affiliation":[{"name":"Department of Research & Support, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6436-2196","authenticated-orcid":false,"given":"Mihyeon","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Research & Support, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8578-2117","authenticated-orcid":false,"given":"Jung Hwan","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology and Metabolism, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7881-9732","authenticated-orcid":false,"given":"Ji Min","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology and Metabolism, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6865-966X","authenticated-orcid":false,"given":"Sunghwan","family":"Suh","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology and Metabolism, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Cheol","family":"Bae","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology and Metabolism, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man Ki","family":"Chung","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology-Head and Neck Surgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6956-1840","authenticated-orcid":false,"given":"Jun-Ho","family":"Choe","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Breast and Endocrine Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Wook","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology & Metabolism, Thyroid Center, Samsung Medical Center, Sungkyunkwan University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9563-5046","authenticated-orcid":false,"given":"Jae Hoon","family":"Chung","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology & Metabolism, Thyroid Center, Samsung Medical Center, Sungkyunkwan University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2081-9251","authenticated-orcid":false,"given":"Young Lyun","family":"Oh","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0865-2236","authenticated-orcid":false,"given":"Kyunga","family":"Kim","sequence":"additional","affiliation":[{"name":"Statistics and Data Center, Research Institute for Future Medicine, Samsung Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Hyuk","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology & Metabolism, Thyroid Center, Samsung Medical Center, Sungkyunkwan University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon Young","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, and Molecular Imaging, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,5,9]]},"reference":[{"key":"R1-20250731","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"R2-20250731","doi-asserted-by":"crossref","first-page":"e210046","DOI":"10.1530\/ETJ-21-0046","article-title":"2022 ETA Consensus Statement: what are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer?","volume":"11","author":"Pacini","year":"2022","journal-title":"Eur Thyroid J"},{"key":"R3-20250731","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1038\/sj.bjc.6601319","article-title":"Second primary malignancies in thyroid cancer patients","volume":"89","author":"Rubino","year":"2003","journal-title":"Br J Cancer"},{"key":"R4-20250731","doi-asserted-by":"crossref","first-page":"djv314.","DOI":"10.1093\/jnci\/djv314","article-title":"Use of radioactive iodine for thyroid cancer and risk of second primary malignancy: a nationwide population-based study","volume":"108","author":"Teng","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"R5-20250731","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1089\/thy.2019.0563","article-title":"Radioiodine-induced salivary gland damage detected by ultrasonography in patients treated for papillary thyroid cancer: radioactive iodine activity and risk","author":"Horvath","year":"2020","journal-title":"Thyroid"},{"key":"R6-20250731","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1089\/thy.2013.0027","article-title":"Extranodal extension of metastatic papillary thyroid carcinoma: correlation with biochemical endpoints, nodal persistence, and systemic disease progression","volume":"23","author":"Lango","year":"2013","journal-title":"Thyroid"},{"key":"R7-20250731","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1089\/thy.2013.0557","article-title":"Extrathyroidal extension predicts extranodal extension in patients with positive lymph nodes: an important association that may affect clinical management","volume":"24","author":"Clain","year":"2014","journal-title":"Thyroid"},{"key":"R8-20250731","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1089\/thy.2012.0043","article-title":"The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension","volume":"22","author":"Randolph","year":"2012","journal-title":"Thyroid"},{"key":"R9-20250731","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.1210\/jc.2005-0285","article-title":"Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and\/or tumor extension beyond the thyroid capsule at initial diagnosis","volume":"90","author":"Leboulleux","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R12-20250731","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/his.13335","article-title":"Crucial parameters in thyroid carcinoma reporting\u2014challenges, controversies and clinical implications","volume":"72","author":"Xu","year":"2018","journal-title":"Histopathology"},{"key":"R13-20250731","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1210\/clinem\/dgad045","article-title":"Radioactive iodine therapy decreases the recurrence of intermediate-risk PTC with low thyroglobulin levels","volume":"108","author":"Tian","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"R14-20250731","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/aje\/kwg115","article-title":"Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders","volume":"158","author":"Cepeda","year":"2003","journal-title":"American journal of epidemiology"},{"key":"R15-20250731","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1210\/clinem\/dgae122","article-title":"Clinical outcomes and implications of radioactive iodine therapy on cancer-specific survival in WHO classification of FTC","volume":"109","author":"Li","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"R17-20250731","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s11864-005-0035-9","article-title":"Papillary thyroid cancer: surgical management of lymph node metastases","volume":"6","author":"Caron","year":"2005","journal-title":"Curr Treat Options Oncol"},{"key":"R18-20250731","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1089\/thy.2015.0551","article-title":"Inter-observer variation in the pathologic identification of extranodal extension in nodal metastasis from papillary thyroid carcinoma","volume":"26","author":"Du","year":"2016","journal-title":"Thyroid"},{"key":"R19-20250731","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1089\/thy.2022.0109","article-title":"Outcomes of papillary thyroid microcarcinoma presenting with pPalpable lateral lymphadenopathy","volume":"32","author":"Papachristos","year":"2022","journal-title":"Thyroid"},{"key":"R20-20250731","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1089\/thy.2018.0541","article-title":"Impact of extranodal extension on risk stratification in papillary thyroid carcinoma","volume":"29","author":"Kim","year":"2019","journal-title":"Thyroid"},{"key":"R21-20250731","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1245\/s10434-016-5594-4","article-title":"Extent of extrathyroidal extension as a significant predictor of nodal metastasis and extranodal extension in patients with papillary thyroid carcinoma","volume":"24","author":"Kim","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"R22-20250731","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/pst.433","article-title":"Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies","volume":"10","author":"Austin","year":"2011","journal-title":"Pharm Stat"},{"key":"R23-20250731","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1007\/s00405-023-08438-3","article-title":"The significance of the presence of extranodal extension in the metastatic node of differentiated thyroid cancer: a proposal for modification in the American Thyroid Association (ATA) risk stratification","volume":"281","author":"Chidambaranathan","year":"2024","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"R24-20250731","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s12020-013-9935-9","article-title":"Should patients with remnants from thyroid microcarcinoma really not be treated with iodine-131 ablation?","volume":"44","author":"Gallicchio","year":"2013","journal-title":"Endocrine"},{"key":"R25-20250731","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/hed.2880110309","article-title":"Metastatic papillary carcinoma of the thyroid: the significance of extranodal extension","volume":"11","author":"Spires","year":"1989","journal-title":"Head Neck"},{"key":"R26-20250731","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1007\/s00268-007-9042-2","article-title":"Extranodal tumor extension to adjacent organs predicts a worse cause-specific survival in patients with papillary thyroid carcinoma","volume":"31","author":"Ito","year":"2007","journal-title":"World J Surg"},{"key":"R27-20250731","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1002\/(SICI)1097-0142(19971215)80:12<2268::AID-CNCR8>3.0.CO;2-Q","article-title":"Extracapsular invasion of lymph node metastasis is an indicator of distant metastasis and poor prognosis in patients with thyroid papillary carcinoma","volume":"80","author":"Yamashita","year":"1997","journal-title":"Cancer"},{"key":"R28-20250731","doi-asserted-by":"crossref","first-page":"4108","DOI":"10.3390\/cancers13164108","article-title":"Extranodal extension predicts poor survival outcomes among patients with bladder cancer","volume":"13","author":"Liao","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R29-20250731","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/modpathol.2011.105","article-title":"Extracapsular extension is a poor predictor of disease recurrence in surgically treated oropharyngeal squamous cell carcinoma","volume":"24","author":"James","year":"2011","journal-title":"Modern Pathology"},{"key":"R30-20250731","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/cen.14544","article-title":"Clinical impact of radioactive iodine dose selection based on the number of metastatic lymph nodes in patients with papillary thyroid carcinoma: a multicenter retrospective cohort study","volume":"95","author":"Kwon","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R31-20250731","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2967\/jnumed.120.243642","article-title":"Unexplained hyperthyroglobulinemia in differentiated thyroid cancer patients as an indication for radioiodine adjuvant therapy: a prospective multicenter study","volume":"62","author":"Cheng","year":"2021","journal-title":"J Nucl Med"},{"key":"R32-20250731","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1210\/jc.2014-1199","article-title":"Prognostic value of microscopic lymph node involvement in patients with papillary thyroid cancer","volume":"100","author":"St\u00e9phane","year":"2015","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005940","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T05:00:37Z","timestamp":1753938037000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005940","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,9]]},"assertion":[{"value":"2025-02-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}